Loading live market data…

Danaher Corporation

NYSE:DHR

$199.05 USD

-$1.11 (-0.55%)

Volume
4.19M
Average Volume
4.65M
Market Capitalization
$140.88B
P/E Ratio
38.35
Dividend Yield
0.72%
Price Target
$230.00
Year High
$242.80
Year Low
$160.93
Day High
Day Low
Payout Ratio
$0.25
Current Ratio
$1.87
Source Headline
Implied Volatility Surging for Danaher Stock Options

Investors need to pay close attention to DHR stock based on the movements in the options market lately.

zacks.com - 2026-07-14 16:41:20

Danaher (DHR) Reports Next Week: Wall Street Expects Earnings Growth

Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-07-14 11:01:06

Abbott Labs Vs. Danaher: Abbott's Everyday Products Beat Danaher's Slumping Biotech Equipment

Abbott Laboratories (NYSE:ABT | ABT Price Prediction) and Danaher (NYSE:DHR) both closed the books on Q1 2026 with very different stories.

247wallst.com - 2026-07-10 14:18:48

VTRS or DHR: Which Is the Better Value Stock Right Now?

Investors interested in Medical Services stocks are likely familiar with Viatris (VTRS) and Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?

zacks.com - 2026-07-09 12:40:44

Will Strength in Biotechnology Unit Continue to Drive DHR's Growth?

Danaher's Biotechnology segment posts 7% core revenue growth as bioprocessing demand strengthened, even as weaker product demand created headwinds.

zacks.com - 2026-07-08 12:51:04

Bet On These 5 Top-Ranked Stocks With Increasing P/E Ratios

Tap these five stocks, W, DHR, ISRG, BEAT and CSW, with rising P/E ratios to try out an out-of-the-box approach.

zacks.com - 2026-07-07 10:31:24

Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

prnewswire.com - 2026-07-03 12:26:00

Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa

WASHINGTON, June 29, 2026 /PRNewswire/ -- The Danaher Foundation, supported by Danaher Corporation (NYSE: DHR), today announced a $1 million commitment to support urgent, on-the-ground response to the Ebola Bundibugyo outbreak in the Democratic Republic of Congo (DRC) and Uganda through Save the Children, the International Rescue Committee (IRC) and the World Food Program USA in support of the World Food Programme (WFP). The funding will be distributed across the three organizations to enable rapid, flexible response to evolving conditions on the ground.

prnewswire.com - 2026-06-29 08:30:00

The Big 3: JPM, DHR, MRK

Dan Deming talks joins today's Big 3 and highlights JPMorgan Chase (JPM) as shares touch new record highs. He sees Danaher (DHR) as a candidate for a continuing breakout, noting a similar pattern in Merck (MRK).

youtube.com - 2026-06-25 13:00:07

Danaher (DHR) Crossed Above the 20-Day Moving Average: What That Means for Investors

Danaher (DHR) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, DHR crossed above the 20-day moving average, suggesting a short-term bullish trend.

zacks.com - 2026-06-25 10:36:04

Danaher Is Down 22% This Year. Is the Masimo Acquisition the Entry Point Investors Have Been Waiting for?

The company is seeing a big uptick in equipment orders. Danaher said it expects its acquisition of Masimo to be accretive to earnings this year.

fool.com - 2026-06-24 13:35:00

VTRS vs. DHR: Which Stock Is the Better Value Option?

Investors interested in Medical Services stocks are likely familiar with Viatris (VTRS) and Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?

zacks.com - 2026-06-23 12:41:04

Danaher Schedules Second Quarter 2026 Earnings Conference Call

WASHINGTON, June 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2026 on Tuesday, July 21, 2026 beginning at 8:00 a.m. ET and lasting approximately one hour.

prnewswire.com - 2026-06-22 16:15:00

The Best Stocks to Invest $1,000 in Right Now

Exploring some of the top bargains in a multi-trillion-dollar industry.

fool.com - 2026-06-22 08:45:00

The Healthcare M&A Wave

In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.

forbes.com - 2026-06-17 12:30:08

Danaher Boosts Product Portfolio With the Acquisition of Masimo

DHR closes its $9.9B Masimo acquisition, adding AI-enabled patient-monitoring and sensor technologies to expand diagnostics solutions.

zacks.com - 2026-06-12 11:06:12

Implied Volatility Surging for Danaher Stock Options

Investors need to pay close attention to DHR stock based on the movements in the options market lately.

zacks.com - 2026-06-12 09:26:08

Strong Performance Continues at DHR's Biotechnology Unit: What's Next?

Danaher is seeing strong Biotechnology growth as bioprocessing demand rises, with equipment orders up more than 30% and core revenue gains expected in 2026.

zacks.com - 2026-06-11 12:16:43

Here Are Thursday’s Best Wall Street Analyst Research Calls: Callaway Golf, Chewy, CME Group, Danaher, General Dynamics, Intel, SpaceX, Rocket Lab, Toast, and More

Pre-Market Stock Futures: Futures are trading higher after a dreadful day on Wall Street, when all the major indices traded lower, and we saw the same pattern that has developed over the last week. The "Buy the Dip" traders come in, briefly get an uptick, and a move higher, and the sellers swarm in to... Here Are Thursday's Best Wall Street Analyst Research Calls: Callaway Golf, Chewy, CME Group, Danaher, General Dynamics, Intel, SpaceX, Rocket Lab, Toast, and More

247wallst.com - 2026-06-11 08:04:30

Danaher Completes Acquisition of Masimo Corporation

WASHINGTON, June 10, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has completed the acquisition of Masimo Corporation, a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care treatment settings. Masimo's trusted brand, advanced sensor technology and AI-enabled patient monitoring bring complementary and powerful new capabilities to the Danaher diagnostics portfolio.

prnewswire.com - 2026-06-10 08:55:00

Sirius XM Holdings Set to Join S&P MidCap 400

NEW YORK, June 8, 2026 /PRNewswire/ -- Sirius XM Holdings Inc. (NASD: SIRI) will replace Masimo Corp. (NASD: MASI) in the S&P MidCap 400 effective prior to the opening of trading on Thursday, June 11. S&P 500 & 100 constituent Danaher Corp. (NYSE: DHR) is acquiring Masimo in a deal expected to be completed soon pending final conditions.

prnewswire.com - 2026-06-08 18:09:00

Baron Discovery Fund Q1 2026: Who Moved The Needle

In the first quarter of 2026, Baron Discovery Fund declined 10.65% (Institutional Shares), trailing the Russell 2000 Growth Index by 7.84% due to significant underperformance in the software sector. Advanced Energy Industries, Inc.'s stock rose during the quarter as the market began to appreciate the strength that the company would see in both its data center and semiconductor end markets. Baron Discovery Fund sold its investment in Intapp, Inc. in the quarter as the team believes that its other software holdings have better overall competitive advantages.

seekingalpha.com - 2026-06-08 01:35:00

Here Are Tuesday’s Top Wall Street Analyst Research Calls: CoreWeave, Danaher, Hewlett Packard Enterprise, Intuit, Knight-Swift, Meta Platforms, Starwood Property Trust, Tripadvisor, and More

Pre-Market Stock Futures: Futures are trading lower on Tuesday, but the technology tsunami continued on Monday, as all major indices dipped into the red early on news that Iran was halting the peace negotiations and would block the Strait of Hormuz. But that sell-off lasted until about noon, before a big reversal, which, by that... Here Are Tuesday's Top Wall Street Analyst Research Calls: CoreWeave, Danaher, Hewlett Packard Enterprise, Intuit, Knight-Swift, Meta Platforms, Starwood Property Trust, Tripadvisor, and More

247wallst.com - 2026-06-02 08:11:52

SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #V55--SCIEX launches the novus V55 system with SCIEX OS 5.0 software and AI enablement tools.

businesswire.com - 2026-06-01 14:00:00

SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #massspec--SCIEX advances the ZenoTOF line with platform-wide expansions in software, integrations, and key collaborations.

businesswire.com - 2026-06-01 14:00:00

A Look at Danaher Corp (DHR) After 4.3% Gain -- GF Value $236.05 vs Price $180.63

On May 28, 2026, Danaher Corp (DHR) shares rose 4.3%, reflecting a positive shift in market sentiment. The stock is currently trading at $180.63, within a 52-we

gurufocus.com - 2026-05-28 17:19:00

11 'Safer' Dividend Dogs Lead 20 May Barron's 2026 Oil And Blue Chips

Barron's Oil & Blue Chip Tips for May 2026 highlight 20 stocks, with 11 deemed 'safer' based on free cash flow yields exceeding dividend yields. Top ten by yield are projected to deliver average net gains of 36.08% by May 2027, with risk/volatility 24% below the market average. Zoetis (ZTS), Danaher (DHR), and Accenture (ACN) lead in projected returns, with ZTS estimated to net 60.33% and lower-than-market volatility.

seekingalpha.com - 2026-05-22 16:32:01

Why Is Danaher (DHR) Down 7% Since Last Earnings Report?

Danaher (DHR) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-05-21 12:31:28

Strength in Danaher's Biotechnology Unit Seems Firm: More Upside Ahead?

DHR's Biotechnology segment posts 7% core revenue growth as bioprocessing demand stayed strong and equipment orders jumped despite headwinds.

zacks.com - 2026-05-20 12:21:07

Here Are Friday’s Top Wall Street Analyst Research Calls: Arista Networks, BWX Technologies, Cisco Systems, Danaher, Doximity, Estee Lauder, Illumina, Texas Roadhouse, Workday, and More

Pre-Market Stock Futures: Futures are trading sharply lower as we get set to end one of the most exciting weeks on Wall Street in 25 years. Positive meetings in China with President Trump, who brought his CEO contingent and Elon Musk, and President Xi, massive upside earnings and forward guidance from an OG tech and... Here Are Friday's Top Wall Street Analyst Research Calls: Arista Networks, BWX Technologies, Cisco Systems, Danaher, Doximity, Estee Lauder, Illumina, Texas Roadhouse, Workday, and More

247wallst.com - 2026-05-15 07:51:48

Danaher Corporation (DHR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Danaher Corporation (DHR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-05-13 17:10:43

Danaher to Present at Bank of America Securities Healthcare Conference

WASHINGTON, May 6, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Wednesday, May 13, 2026 at 11:20 a.m.

prnewswire.com - 2026-05-06 16:15:00

Danaher Announces Quarterly Dividend

WASHINGTON, May 5, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 31, 2026 to holders of record on June 26, 2026. ABOUT DANAHER Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health.

prnewswire.com - 2026-05-05 16:30:00

Masimo Shareholders Approve Acquisition by Danaher

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced Agreement and Plan of Merger, dated February 16, 2026 (the “Merger Agreement”), by and among Masimo, Danaher Corporation (“Danaher”) (NYSE: DHR) and Mobius Merger Sub, Inc. (the “Merger Sub”) at Masimo's special meeting of stockholders held virtually on May 1, 2026 (.

businesswire.com - 2026-05-04 09:00:00

Xylem Q1 Earnings Beat Estimates, Revenues Increase Y/Y

XYL tops Q1 estimates as Measurement & Control demand lifts results, while raising 2026 revenue outlook.

zacks.com - 2026-04-28 12:26:18

Danaher Corporation $DHR Shares Purchased by AEGON ASSET MANAGEMENT UK Plc

AEGON ASSET MANAGEMENT UK Plc lifted its stake in shares of Danaher Corporation (NYSE: DHR) by 81.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 328,147 shares of the conglomerate's stock after purchasing an additional 146,929 shares during the quarter. Danaher comprises

defenseworld.net - 2026-04-26 03:07:05

Calamos Advisors LLC Has $55.79 Million Stock Position in Danaher Corporation $DHR

Calamos Advisors LLC boosted its holdings in Danaher Corporation (NYSE: DHR) by 9.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 243,698 shares of the conglomerate's stock after purchasing an additional 20,180 shares during the quarter. Calamos Advisors LLC's

defenseworld.net - 2026-04-25 04:07:26

This Stock Is Up Over 52,700% Since Founding. Should Investors Buy After Its 36% Decline?

This blue chip stock has been in a multiyear slump, but things are looking up.

fool.com - 2026-04-24 14:15:00

Arizona State Retirement System Sells 6,790 Shares of Danaher Corporation $DHR

Arizona State Retirement System decreased its position in shares of Danaher Corporation (NYSE: DHR) by 3.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 181,341 shares of the conglomerate's stock after selling 6,790 shares during the period. Arizona State Retirement System's

defenseworld.net - 2026-04-24 03:48:45

Danaher reaches $172.5 million settlement with shareholders over post-pandemic outlook

Danaher reached a $172.5 million settlement with shareholders who accused the diagnostics and ​life-sciences company of defrauding them by overstating ‌demand for its equipment as the worst of the COVID-19 pandemic passed.

reuters.com - 2026-04-23 13:39:28

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

WASHINGTON, April 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced an offering of the following euro-denominated senior notes (the "Offering"): €500,000,000 principal amount of floating rate senior notes due 2028 at an offering price of 100.000% of the principal amount; €750,000,000 principal amount of 3.250% senior notes due 2030 at an offering price of 99.934% of the principal amount; €750,000,000 principal amount of 3.625% senior notes due 2034 at an offering price of 99.918% of the principal amount; and €1,000,000,000 principal amount of 4.000% senior notes due 2038 at an offering price of 99.953% of the principal amount (collectively, the "senior notes"). Danaher estimates that the net proceeds from the sale of the senior notes will be approximately €2.98 billion, after deducting the underwriting discounts and estimated offering expenses payable by Danaher.

prnewswire.com - 2026-04-22 19:15:00

Danaher Q1 2026 Earnings Update

Danaher had another somewhat uneventful quarter. Margin in biotechnology segment improved YoY to reach 42.7% in 1Q'26. Life Sciences segment's core revenue grew at only 0.5% despite having an easy comp of -4% in 1Q'25.

seekingalpha.com - 2026-04-22 14:30:00

Danaher Q1 Earnings Call Highlights

Danaher (NYSE: DHR) reported first-quarter 2026 sales of $6.0 billion, with core revenue up 0.5% year over year as strength in bioprocessing and better-than-expected life sciences performance largely offset a lighter-than-normal respiratory season at Cepheid. President and CEO Rainer Blair said the company delivered "better than expected adjusted EPS growth" by "leveraging the Danaher Business System

defenseworld.net - 2026-04-22 04:58:52

Danaher Q1 Earnings Beat Estimates, Life Sciences Sales Up Y/Y

DHR beats Q1 EPS estimates and lifts 2026 outlook, but revenues miss as Diagnostics lags while bioprocessing strength and Masimo deal shape growth plans.

zacks.com - 2026-04-21 13:31:12

LH or DHR: Which Is the Better Value Stock Right Now?

Investors interested in Medical Services stocks are likely familiar with Labcorp Holdings (LH) and Danaher (DHR). But which of these two stocks is more attractive to value investors?

zacks.com - 2026-04-21 12:42:16

Danaher Q1 Earnings Beat Estimates, But Revenue Miss, Weak Diagnostics Weigh On Stock

Danaher Corp (NYSE:DHR) on Tuesday reported first-quarter 2026 sales of $5.95 billion, up 3.5% year-over-year, but under the consensus of $5.99 billion. Core revenue increased 0.5% year-over-year.

benzinga.com - 2026-04-21 12:00:42

Danaher Corporation (DHR) Q1 2026 Earnings Call Transcript

Danaher Corporation (DHR) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-04-21 11:20:58

Danaher (DHR) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Danaher (DHR) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

zacks.com - 2026-04-21 10:31:39

Danaher Corp. May Be the Smartest Bet in Biotech Right Now

If biotech funding continues to increase this year, Danaher could benefit.

fool.com - 2026-04-21 08:46:00

Danaher (DHR) Q1 Earnings Beat Estimates

Danaher (DHR) came out with quarterly earnings of $2.06 per share, beating the Zacks Consensus Estimate of $1.95 per share. This compares to earnings of $1.88 per share a year ago.

zacks.com - 2026-04-21 08:15:32

Get DHR Insider Trade Alerts

DHR Price Target Summary

Last Month

$230.00

1 analysts

Last Quarter

$222.71

7 analysts

Last Year

$239.35

20 analysts

All Time

$276.68

53 analysts

DHR Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-07-06 Evercore ISI Group Maintain Outperform Outperform
2026-06-11 Piper Sandler Maintain Neutral Neutral
2026-06-03 HSBC Maintain Buy Buy
2026-05-27 Citigroup Downgrade Buy Neutral
2026-04-23 Morgan Stanley Maintain Overweight Overweight
2026-04-22 UBS Maintain Buy Buy
2026-04-22 Baird Maintain Outperform Outperform
2026-04-22 Guggenheim Maintain Buy Buy
2026-04-22 Wells Fargo Maintain Equal Weight Equal Weight
2026-04-17 Baird Maintain Outperform Outperform
2026-04-14 Barclays Maintain Overweight Overweight
2026-04-13 Goldman Sachs Maintain Buy Buy
2026-04-06 Evercore ISI Group Maintain Outperform Outperform
2026-01-29 Jefferies Maintain Buy Buy
2026-01-29 JP Morgan Maintain Overweight Overweight
2026-01-07 TD Cowen Maintain Buy Buy
2026-01-05 Guggenheim Maintain Buy Buy
2025-12-15 Wells Fargo Maintain Equal Weight Equal Weight
2025-10-23 Wells Fargo Maintain Equal Weight Equal Weight
2025-10-22 Barclays Maintain Overweight Overweight
2025-10-22 TD Cowen Maintain Buy Buy
2025-10-08 Rothschild & Co Downgrade Buy Neutral
2025-10-07 Evercore ISI Group Maintain Outperform Outperform
2025-09-22 B of A Securities Maintain Buy Buy
2025-07-23 Wells Fargo Maintain Equal Weight Equal Weight
2025-07-23 Guggenheim Maintain Buy Buy
2025-07-23 UBS Maintain Buy Buy
2025-07-23 Baird Maintain Outperform Outperform
2025-07-18 Baird Maintain Outperform Outperform
2025-07-11 Scotiabank Upgrade Sector Perform Sector Outperform
2025-07-08 Evercore ISI Group Maintain Outperform Outperform
2025-06-24 Barclays Maintain Overweight Overweight
2025-04-23 Guggenheim Maintain Buy Buy
2025-04-23 Goldman Sachs Maintain Buy Buy
2025-04-23 RBC Capital Maintain Outperform Outperform
2025-04-23 Baird Maintain Outperform Outperform
2025-04-23 UBS Maintain Buy Buy
2025-04-22 Barclays Maintain Overweight Overweight
2025-04-22 JP Morgan Maintain Overweight Overweight
2025-04-22 Jefferies Maintain Buy Buy
2025-04-16 Baird Maintain Outperform Outperform
2025-04-10 Barclays Upgrade Equal Weight Overweight
2025-03-14 Stifel Upgrade Hold Buy
2025-02-03 Raymond James Downgrade Outperform Market Perform
2025-01-30 Baird Maintain Outperform Outperform
2025-01-30 RBC Capital Maintain Outperform Outperform
2025-01-30 Barclays Maintain Equal Weight Equal Weight
2025-01-30 Wells Fargo Maintain Equal Weight Equal Weight
2025-01-30 Citigroup Maintain Buy Buy
2025-01-29 Jefferies Maintain Buy Buy
2025-01-21 Raymond James Maintain Outperform Outperform
2025-01-06 Citigroup Maintain Buy Buy
2024-12-13 B of A Securities Upgrade Neutral Buy
2024-10-31 Wolfe Research Upgrade Peer Perform Outperform
2024-10-23 Keybanc Maintain Overweight Overweight
2024-10-23 TD Cowen Maintain Buy Buy
2024-10-23 Barclays Maintain Equal Weight Equal Weight
2024-10-23 UBS Maintain Buy Buy
2024-10-23 Raymond James Maintain Outperform Outperform
2024-10-23 Stifel Maintain Hold Hold
2024-10-23 Baird Maintain Outperform Outperform
2024-10-23 RBC Capital Maintain Outperform Outperform
2024-10-23 Stephens & Co. Maintain Overweight Overweight
2024-10-01 Evercore ISI Group Maintain Outperform Outperform
2024-09-06 RBC Capital Maintain Outperform Outperform
2024-07-24 Leerink Partners Maintain Outperform Outperform
2024-07-24 TD Cowen Maintain Buy Buy
2024-07-24 Stifel Maintain Hold Hold
2024-07-24 B of A Securities Maintain Neutral Neutral
2024-07-24 Barclays Maintain Equal Weight Equal Weight
2024-07-24 RBC Capital Maintain Outperform Outperform
2024-07-24 Baird Maintain Outperform Outperform
2024-07-24 Goldman Sachs Maintain Neutral Neutral
2024-07-02 Evercore ISI Group Maintain Outperform Outperform
2024-04-24 B of A Securities Maintain Neutral Neutral
2024-04-24 Barclays Maintain Equal Weight Equal Weight
2024-04-24 Baird Maintain Outperform Outperform
2024-04-24 Citigroup Maintain Buy Buy
2024-04-24 TD Cowen Maintain Buy Buy
2024-04-17 HSBC Upgrade Hold Buy
2024-04-10 Barclays Maintain Equal Weight Equal Weight
2024-02-01 Keybanc Maintain Overweight Overweight
2024-01-31 RBC Capital Maintain Outperform Outperform
2024-01-31 Raymond James Maintain Outperform Outperform
2024-01-31 Citigroup Maintain Buy Buy
2024-01-24 Barclays Downgrade Overweight Equal Weight
2023-12-20 JP Morgan Maintain Overweight Overweight
2023-12-11 Citigroup Maintain Buy Buy
2023-12-07 Goldman Sachs Downgrade Buy Neutral
2023-10-26 Goldman Sachs Maintain Buy Buy
2023-10-26 Barclays Maintain Overweight Overweight
2023-10-25 Citigroup Maintain Buy Buy
2023-10-25 Keybanc Maintain Overweight Overweight
2023-10-25 JP Morgan Maintain Overweight Overweight
2023-10-25 Raymond James Maintain Outperform Outperform
2023-10-25 RBC Capital Maintain Outperform Outperform
2023-10-18 Raymond James Maintain Outperform Outperform
2023-10-17 JP Morgan Maintain Overweight Overweight
2023-10-03 Wells Fargo Maintain Overweight Overweight
2023-09-27 Keybanc Maintain Overweight Overweight
2023-07-26 Stifel Maintain Hold Hold
2023-07-26 Raymond James Maintain Outperform Outperform
2023-07-26 Barclays Maintain Overweight Overweight
2023-07-26 RBC Capital Maintain Outperform Outperform
2023-04-27 Deutsche Bank Maintain Buy Buy
2023-04-26 TD Cowen Maintain Outperform Outperform
2023-04-26 Citigroup Maintain Buy Buy
2023-04-26 Goldman Sachs Maintain Buy Buy
2023-04-26 B of A Securities Downgrade Buy Neutral
2023-04-26 RBC Capital Maintain Outperform Outperform
2023-04-26 Credit Suisse Maintain Neutral Neutral
2023-04-26 Stifel Maintain Hold Hold
2023-04-26 Baird Maintain Outperform Outperform
2023-04-26 Barclays Maintain Overweight Overweight
2023-04-18 Wells Fargo Upgrade Equal Weight Overweight
2023-04-04 Barclays Maintain Overweight Overweight
2023-01-25 Cowen & Co. Maintain Outperform Outperform
2023-01-24 Baird Maintain Outperform Outperform
2023-01-24 Barclays Maintain Overweight Overweight
2023-01-05 Credit Suisse Downgrade Outperform Neutral
2022-11-29 Barclays Maintain Overweight Overweight
2022-10-24 Benchmark Downgrade Buy Hold
2022-10-24 RBC Capital Maintain Outperform Outperform
2022-10-21 JP Morgan Maintain Overweight Overweight
2022-10-21 RBC Capital Maintain Outperform Outperform
2022-10-21 Baird Maintain Outperform Outperform
2022-10-06 Barclays Maintain Overweight Overweight
2022-09-20 Benchmark Maintain Buy Buy
2022-09-16 RBC Capital Maintain Outperform Outperform
2022-07-28 UBS Maintain Buy Buy
2022-07-22 Keybanc Maintain Overweight Overweight
2022-07-22 RBC Capital Maintain Outperform Outperform
2022-07-22 Barclays Maintain Overweight Overweight
2022-07-13 Barclays Maintain Overweight Overweight
2022-06-01 RBC Capital Upgrade Sector Perform Outperform
2022-04-25 Wells Fargo Downgrade Overweight Equal Weight
2022-04-22 RBC Capital Maintain Sector Perform Sector Perform
2022-01-28 Wells Fargo Maintain Overweight Overweight
2022-01-27 Barclays Maintain Overweight Overweight
2021-12-14 Wells Fargo Maintain Overweight Overweight
2021-10-22 RBC Capital Maintain Sector Perform Sector Perform
2021-10-22 Keybanc Maintain Overweight Overweight
2021-10-22 Barclays Maintain Overweight Overweight
2021-09-10 Credit Suisse Maintain Outperform Outperform
2021-09-08 RBC Capital Maintain Sector Perform Sector Perform
2021-07-23 RBC Capital Maintain Sector Perform Sector Perform
2021-07-23 Barclays Maintain Overweight Overweight
2021-07-13 Barclays Maintain Overweight Overweight
2021-06-18 Credit Suisse Maintain Outperform Outperform
2021-04-26 Barclays Maintain Overweight Overweight
2021-04-23 Wells Fargo Maintain Overweight Overweight
2021-04-23 Keybanc Maintain Overweight Overweight
2021-01-14 Credit Suisse Maintain Outperform Outperform
2020-11-25 RBC Capital Downgrade Outperform Sector Perform
2020-07-27 Needham Maintain Buy Buy
2020-07-27 UBS Maintain Buy Buy
2020-07-24 Jefferies Maintain Buy Buy
2020-07-24 Stifel Maintain Hold Hold
2020-07-20 B of A Securities Maintain Buy Buy
2020-05-21 Credit Suisse Maintain Outperform Outperform
2020-05-15 Needham Maintain Buy Buy
2020-05-11 RBC Capital Maintain Outperform Outperform
2020-05-08 Citigroup Maintain Buy Buy
2020-05-08 Stifel Maintain Hold Hold
2020-04-21 Wells Fargo Maintain Overweight Overweight
2020-04-20 Citigroup Maintain Buy Buy
2020-04-02 Stifel Maintain Hold Hold
2020-03-30 Wells Fargo Maintain Overweight Overweight
2020-03-26 RBC Capital Upgrade Sector Perform Outperform
2020-03-20 Citigroup Maintain Buy Buy
2020-02-03 Needham Maintain Buy Buy
2020-01-31 B of A Securities Maintain Buy Buy
2020-01-31 Citigroup Maintain Buy Buy
2020-01-31 Stifel Maintain Hold Hold
2020-01-31 Baird Maintain Outperform Outperform
2020-01-31 Stifel Nicolaus Maintain Hold Hold
2020-01-10 UBS Maintain Neutral Neutral
2020-01-02 Needham Maintain Buy Buy
2019-12-19 Credit Suisse Maintain Outperform Outperform
2019-12-02 UBS Maintain Buy Buy
2018-10-19 Baird Maintain Outperform Outperform
2018-10-10 Morgan Stanley Maintain Overweight Overweight
2018-07-20 Morgan Stanley Maintain Overweight Overweight
2018-07-13 Morgan Stanley Maintain Overweight Overweight
2018-04-20 Morgan Stanley Maintain Overweight Overweight
2018-04-20 Stifel Nicolaus Maintain Buy Buy
2018-04-20 Stifel Maintain Buy Buy
2018-04-10 Morgan Stanley Maintain Overweight Overweight
2018-03-13 Credit Suisse Maintain Outperform Outperform
2018-03-01 Deutsche Bank Maintain Buy Buy
2018-02-01 Argus Maintain Buy Buy
2018-02-01 Argus Research Maintain Buy Buy
2018-01-31 Credit Suisse Maintain Outperform Outperform
2018-01-31 Stifel Maintain Buy Buy
2018-01-31 Morgan Stanley Maintain Overweight Overweight
2018-01-31 Stifel Nicolaus Maintain Buy Buy
2017-10-20 Credit Suisse Maintain Outperform Outperform
2017-10-20 Baird Maintain Outperform Outperform
2017-10-20 Morgan Stanley Maintain Overweight Overweight
2017-10-06 Morgan Stanley Maintain Overweight Overweight
2017-07-21 Citigroup Maintain Buy Buy
2017-06-07 Janney Montgomery Scott Downgrade Buy Neutral
2017-06-07 Janney Capital Downgrade Buy Neutral
2017-02-24 Citigroup Upgrade Neutral Buy
2017-02-01 Credit Suisse Upgrade Neutral Outperform
2016-11-11 Cowen & Co. Upgrade Market Perform Outperform
2016-09-07 Barclays Maintain Overweight Overweight
2016-07-27 Citigroup Maintain Neutral Neutral
2016-07-11 Barclays Maintain Overweight Overweight
2016-06-24 Bernstein Upgrade Market Perform Outperform
2016-06-13 Citigroup Maintain Neutral Neutral
2016-04-25 Sterne Agee CRT Maintain Neutral Neutral
2016-04-25 Sterne Agee Maintain Neutral Neutral
2016-04-19 Citigroup Maintain Neutral Neutral
2016-04-18 Barclays Maintain Overweight Overweight
2016-04-04 Bernstein Downgrade Outperform Market Perform
2016-01-27 Credit Suisse Maintain Neutral Neutral
2016-01-19 Barclays Maintain Overweight Overweight
2015-12-17 Barclays Maintain Overweight Overweight
2015-12-08 Goldman Sachs Downgrade Buy Neutral
2015-10-23 Barclays Maintain Overweight Overweight
2015-10-05 Barclays Maintain Overweight Overweight
2015-10-01 Stifel Nicolaus Maintain Buy Buy
2015-10-01 Stifel Maintain Buy Buy
2015-09-09 RBC Capital Maintain Sector Perform Sector Perform
2015-09-04 Credit Suisse Maintain Neutral Neutral
2015-07-28 Morgan Stanley Upgrade Equal Weight Overweight
2015-05-26 Barclays Maintain Overweight Overweight
2015-05-14 Stifel Maintain Buy Buy
2015-05-14 Stifel Nicolaus Maintain Buy Buy
2015-05-13 Deutsche Bank Maintain Hold Hold
2015-03-17 Barclays Maintain Overweight Overweight
2015-01-28 JP Morgan Maintain Overweight Overweight
2015-01-27 Stifel Maintain Buy Buy
2015-01-27 Barclays Maintain Overweight Overweight
2015-01-15 JP Morgan Maintain Overweight Overweight
2015-01-11 Morgan Stanley Downgrade Overweight Equal Weight
2014-12-12 Barclays Maintain Overweight Overweight
2014-12-08 Jefferies Maintain Buy Buy
2014-11-12 FBR Capital Upgrade Market Perform Outperform
2014-10-17 Credit Suisse Maintain Neutral Neutral
2014-10-17 Barclays Maintain Overweight Overweight
2014-10-16 Morgan Stanley Maintain Overweight Overweight
2014-10-06 Barclays Maintain Overweight Overweight
2014-07-24 Barclays Maintain Overweight Overweight
2014-04-09 ISI Group Upgrade Buy Strong Buy
2014-01-17 S&P Capital IQ Downgrade Hold Sell
2014-01-14 B of A Securities Upgrade Neutral Buy
2014-01-14 Bank of America Upgrade Neutral Buy
2013-07-10 Morgan Stanley Maintain Overweight Overweight
2013-06-20 Jefferies Maintain Buy Buy
2013-03-25 Deutsche Bank Maintain Hold Hold
2013-03-18 Citigroup Maintain Buy Buy
2013-03-04 Ladenburg Thalmann Maintain Buy Buy
2013-01-30 UBS Maintain Buy Buy
2013-01-30 Credit Suisse Maintain Outperform Outperform
2013-01-30 BMO Capital Maintain Outperform Outperform
2013-01-30 Jefferies Maintain Buy Buy
2013-01-30 Barclays Maintain Overweight Overweight
2013-01-29 ISI Group Maintain Buy Buy
2013-01-09 Jefferies Maintain Buy Buy
2013-01-07 ISI Group Upgrade Neutral Buy
2013-01-07 Deutsche Bank Maintain Hold Hold
2012-12-13 ISI Group Maintain Market Weight Market Weight
2012-10-22 JP Morgan Maintain Overweight Overweight
2012-10-18 ISI Group Maintain Market Weight Market Weight
2012-09-10 JP Morgan Maintain Overweight Overweight
2012-09-05 Citigroup Maintain Buy Buy
2012-07-19 Morgan Stanley Maintain Overweight Overweight
2012-07-18 ISI Group Maintain Market Weight Market Weight
2012-07-12 Citigroup Maintain Buy Buy
2012-07-09 Morgan Stanley Maintain Overweight Overweight
2012-04-20 Jefferies Maintain Buy Buy
2012-04-20 JP Morgan Maintain Overweight Overweight